bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 73.90
+0.80 (1.09%)
Aug 20, 2026, 4:34 PM CET
bioMérieux Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,991 | 4,070 | 3,980 | 3,675 | 3,589 | 3,376 |
Revenue Growth | -1.95% | 2.26% | 8.30% | 2.38% | 6.31% | 8.27% |
Gross Profit Gross Profit Growth | 2,240 | 2,309 | 2,215 | 2,057 | 2,009 | 2,001 |
Operating Income Operating Income Growth | 639.8 | 694.8 | 637.9 | 569 | 613 | 813.5 |
Net Income Net Income Growth | 462.6 | 397.5 | 432.2 | 357.6 | 452.4 | 601.1 |
Earnings Per Share EPS Growth | 3.90 | 3.34 | 3.64 | 3.01 | 3.82 | 5.06 |
EPS Growth | 16.78% | -8.24% | 20.93% | -21.20% | -24.51% | 48.39% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Industrial Applications Industrial Applications Growth | 649.9 | 638.9 | 606 | 575.3 | 549 | 492.6 |
Clinical Applications Clinical Applications Growth | 3,341 | 3,431 | 3,374 | 3,099 | 3,040 | 2,883 |
Total Total Growth | 3,990 | 4,070 | 3,980 | 3,675 | 3,589 | 3,376 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 657.7 | 569.8 | 449.8 | 352.4 | 552.6 | 803.5 |
Total Debt Total Debt Growth | 421.8 | 461.4 | 490.7 | 518.8 | 505.4 | 462.5 |
Net Cash (Debt) Net Cash Growth | 235.9 | 108.4 | -40.9 | -166.4 | 47.2 | 341 |
Net Cash Growth | 117.62% | - | - | - | -86.16% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.99 | 0.91 | -0.34 | -1.40 | 0.40 | 2.87 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 905.1 | 788.4 | 667.3 | 445.4 | 475.1 | 824.7 |
Capital Expenditures CapEx Growth | -322.1 | -335.3 | -345.8 | -338.3 | -286.7 | -290.1 |
Free Cash Flow Free Cash Flow Growth | 583 | 453.1 | 321.5 | 107.1 | 188.4 | 534.6 |
Free Cash Flow Growth | 28.67% | 40.93% | 200.19% | -43.15% | -64.76% | 75.11% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 56.13% | 56.73% | 55.66% | 55.99% | 55.97% | 59.26% |
Operating Margin | 16.03% | 17.07% | 16.03% | 15.48% | 17.08% | 24.09% |
Pretax Margin | 15.21% | 12.92% | 14.56% | 11.90% | 16.18% | 22.92% |
Profit Margin | 11.59% | 9.77% | 10.86% | 9.73% | 12.61% | 17.80% |
FCF Margin | 14.61% | 11.13% | 8.08% | 2.92% | 5.25% | 15.83% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.980 | 0.980 | 0.900 | 0.850 | 0.850 | 0.850 |
Dividend Per Share Growth | 8.89% | 8.89% | 5.88% | 0% | 0% | 37.10% |
Dividend Yield | 1.34% | 0.90% | 0.89% | 0.87% | 0.90% | 0.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.74 | 32.76 | 28.26 | 33.23 | 25.62 | 24.59 |
Forward PE | 16.23 | 22.62 | 23.05 | 23.60 | 25.48 | 31.25 |
P/FCF Ratio | 14.76 | 28.74 | 37.99 | 110.96 | 61.52 | 27.65 |
PS Ratio | 2.16 | 3.20 | 3.07 | 3.23 | 3.23 | 4.38 |